The clinical and immunologic features of pulmonary fibrosis in sarcoidosis

Translational Research

Volumn 160, Issue 5, 2012, Pages 321-331

  Patterson, Karen C ^a   Hogarth, Kyle ^a   Husain, Aliya N ^a   Sperling, Anne I ^a   Niewold, Timothy B ^a,b  

^a UNIVERSITY OF CHICAGO   (United States)

^b UNIVERSITY OF CHICAGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BONE MORPHOGENETIC PROTEIN; C REACTIVE PROTEIN; CYTOKINE; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERLEUKIN 1; INTERLEUKIN 12; INTERLEUKIN 15; INTERLEUKIN 18; INTERLEUKIN 6; TRANSFORMING GROWTH FACTOR BETA;

ANTIINFLAMMATORY ACTIVITY; ARTICLE; ASPERGILLOMA; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL ACTIVATION; CLINICAL FEATURE; DISEASE COURSE; EXTRACELLULAR MATRIX; FIBROBLAST; FIBROSING ALVEOLITIS; GENE EXPRESSION; GENOTYPE; GRANULOMATOUS INFLAMMATION; HELPER CELL; HISTOPATHOLOGY; HOMEOSTASIS; HUMAN; IMMUNITY; IMMUNOPATHOLOGY; LUNG FUNCTION; LUNG SARCOIDOSIS; LYMPHOCYTE; MACROPHAGE; MORBIDITY; MORTALITY; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PULMONARY HYPERTENSION; RADIOGRAPHY; REGULATORY MECHANISM; REGULATORY T LYMPHOCYTE; REMISSION; SIGNAL TRANSDUCTION; TH2 CELL; TISSUE REGENERATION; WOUND HEALING;

EID: 84867567110     PISSN: 19315244     EISSN: 18781810     Source Type: Journal    
DOI: 10.1016/j.trsl.2012.03.005     Document Type: Review

References (93)

1. A. Prasse, C. Katic, M. Germann, A. Buchwald, G. Zissel, and J. Muller-Quernheim Phenotyping sarcoidosis from a pulmonary perspective Am J Respir Crit Care Med 177 2008 330 336
2. M.C. Iannuzzi, and J.R. Fontana Sarcoidosis: clinical presentation, immunopathogenesis, and therapeutics JAMA 305 2011 391 399
3. R.P. Baughman, D.B. Winget, E.H. Bowen, and E.E. Lower Predicting respiratory failure in sarcoidosis patients Sarcoidosis Vasc Diffuse Lung Dis 14 1997 154 158
4. A.S. Hennebicque, H. Nunes, P.Y. Brillet, H. Moulahi, D. Valeyre, and M.W. Brauner CT findings in severe thoracic sarcoidosis Eur Radiol 15 2005 23 30
5. N.M. Gideon, and D.M. Mannino Sarcoidosis mortality in the United States 1979-1991: an analysis of multiple-cause mortality data Am J Med 100 1996 423 427
6. A.T. Teirstein, and A.S. Morgenthau "End-stage" pulmonary fibrosis in sarcoidosis Mt Sinai J Med 76 2009 30 36
7. A. Nardi, P.Y. Brillet, and P. Letoumelin Stage IV sarcoidosis: comparison of survival with the general population and causes of death Eur Respir J 38 2011 1368 1373
8. J.J. Swigris, A.L. Olson, and T.J. Huie Sarcoidosis-related mortality in the United States from 1988 to 2007 Am J Respir Crit Care Med 183 2011 1524 1530
9. J.P. Lynch III, Y.L. Ma, M.N. Koss, and E.S. White Pulmonary sarcoidosis Semin Respir Crit Care Med 28 2007 53 74
10. S. Pabst, T. Franken, J. Schonau, S. Stier, G. Nickenig, and R. Meyer Transforming growth factor-β gene polymorphisms in different phenotypes of sarcoidosis Eur Respir J 38 2011 169 175
11. M. Abehsera, D. Valeyre, P. Grenier, H. Jaillet, J.P. Battesti, and M.W. Brauner Sarcoidosis with pulmonary fibrosis: CT patterns and correlation with pulmonary function AJR Am J Roentgenol 174 2000 1751 1757
12. Y. Ma, A. Gal, and M.N. Koss The pathology of pulmonary sarcoidosis: update Semin Diagn Pathol 24 2007 150 161
13. F. Lavergne, C. Clerici, D. Sadoun, M. Brauner, J.P. Battesti, and D. Valeyre Airway obstruction in bronchial sarcoidosis: outcome with treatment Chest 116 1999 1194 1199
14. S.M. Arcasoy, J.D. Christie, and A. Pochettino Characteristics and outcomes of patients with sarcoidosis listed for lung transplantation Chest 120 2001 873 880
15. H. Nunes, M. Humbert, and F. Capron Pulmonary hypertension associated with sarcoidosis: mechanisms, haemodynamics and prognosis Thorax 61 2006 68 74
16. H.E. Lockstone, S. Sanderson, and N. Kulakova Gene set analysis of lung samples provides insight into pathogenesis of progressive, fibrotic pulmonary sarcoidosis Am J Respir Crit Care Med 181 2010 1367 1375
17. T.E. King Jr., J.A. Tooze, M.I. Schwarz, K.R. Brown, and R.M. Cherniack Predicting survival in idiopathic pulmonary fibrosis: scoring system and survival model Am J Respir Crit Care Med 164 2001 1171 1181
18. M.A. Judson An approach to the treatment of pulmonary sarcoidosis with corticosteroids: the six phases of treatment Chest 115 1999 1158 1165
19. J.G. Scadding A "burnt-out" case of sarcoidosis Postgrad Med J 44 1968 105 108
20. M. Remy-Jardin, F. Giraud, J. Remy, L. Wattinne, B. Wallaert, and A. Duhamel Pulmonary sarcoidosis: role of CT in the evaluation of disease activity and functional impairment and in prognosis assessment Radiology 191 1994 675 680
21. E. Criado, M. Sanchez, and J. Ramirez Pulmonary sarcoidosis: typical and atypical manifestations at high-resolution CT with pathologic correlation Radiographics 30 2010 1567 1586
22. H. Shigemitsu, J.M. Oblad, O.P. Sharma, and M.N. Koss Chronic interstitial pneumonitis in end-stage sarcoidosis Eur Respir J 35 2010 695 697
23. D.S. Kim, H.R. Collard, and T.E. King Jr. Classification and natural history of the idiopathic interstitial pneumonias Proc Am Thorac Soc 3 2006 285 292
24. M. Mollers, S.P. Aries, D. Dromann, B. Mascher, J. Braun, and K. Dalhoff Intracellular cytokine repertoire in different T cell subsets from patients with sarcoidosis Thorax 56 2001 487 493
25. L.S. Newman, C.S. Rose, and L.A. Maier Sarcoidosis N Engl J Med 336 1997 1224 1234
26. D.R. Moller Cells and cytokines involved in the pathogenesis of sarcoidosis Sarcoidosis Vasc Diffuse Lung Dis 16 1999 24 31
27. D.R. Moller Pulmonary fibrosis of sarcoidosis. New approaches, old ideas Am J Respir Cell Mol Biol 29 2003 S37 S41
28. D.R. Moller Potential etiologic agents in sarcoidosis Proc Am Thorac Soc 4 2007 465 468
29. G.W. Hunninghake, and R.G. Crystal Mechanisms of hypergammaglobulinemia in pulmonary sarcoidosis. Site of increased antibody production and role of T lymphocytes J Clin Invest 67 1981 86 92
30. J. Wahlstrom, K. Katchar, H. Wigzell, O. Olerup, A. Eklund, and J. Grunewald Analysis of intracellular cytokines in CD4+ and CD8+ lung and blood T cells in sarcoidosis Am J Respir Crit Care Med 163 2001 115 121
31. J. Muller-Quernheim Sarcoidosis: immunopathogenetic concepts and their clinical application Eur Respir J 12 1998 716 738
32. S.A. Antoniu Targeting the TNF-α pathway in sarcoidosis Expert Opin Ther Targets 14 2010 21 29
33. M. Drent, J.A. Jacobs, J. de Vries, R.J. Lamers, I.H. Liem, and E.F. Wouters Does the cellular bronchoalveolar lavage fluid profile reflect the severity of sarcoidosis? Eur Respir J 13 1999 1338 1344
34. G. Zissel, J. Homolka, J. Schlaak, M. Schlaak, and J. Muller-Quernheim Anti-inflammatory cytokine release by alveolar macrophages in pulmonary sarcoidosis Am J Respir Crit Care Med 154 1996 713 719
35. M. Miyara, Z. Amoura, and C. Parizot The immune paradox of sarcoidosis and regulatory T cells J Exp Med 203 2006 359 370
36. S. Hofmann, A. Franke, and A. Fischer Genome-wide association study identifies ANXA11 as a new susceptibility locus for sarcoidosis Nat Genet 40 2008 1103 1106
37. R. Valentonyte, J. Hampe, and K. Huse Sarcoidosis is associated with a truncating splice site mutation in BTNL2 Nat Genet 37 2005 357 364
38. M.J. Hayes, R.E. Longbottom, M.A. Evans, and S.E. Moss Annexinopathies Subcell Biochem 45 2007 1 28
39. T. Nguyen, X.K. Liu, Y. Zhang, and C. Dong BTNL2, a butyrophilin-like molecule that functions to inhibit T cell activation J Immunol 176 2006 7354 7360
40. S.M. Wahl, J. Swisher, N. McCartney-Francis, and W. Chen TGF-β: the perpetrator of immune suppression by regulatory T cells and suicidal T cells J Leukoc Biol 76 2004 15 24
41. A. Goodwin, and G. Jenkins Role of integrin-mediated TGFβ activation in the pathogenesis of pulmonary fibrosis Biochem Soc Trans 37 2009 849 854
42. M. Gharaee-Kermani, B. Hu, S.H. Phan, and M.R. Gyetko Recent advances in molecular targets and treatment of idiopathic pulmonary fibrosis: focus on TGFβ signaling and the myofibroblast Curr Med Chem 16 2009 1400 1407
43. A. Xaubet, A. Marin-Arguedas, and S. Lario Transforming growth factor-β1 gene polymorphisms are associated with disease progression in idiopathic pulmonary fibrosis Am J Respir Crit Care Med 168 2003 431 435
44. W.A. Border, and N.A. Noble Transforming growth factor β in tissue fibrosis N Engl J Med 331 1994 1286 1292
45. J. Ito, N. Harada, and O. Nagashima Wound-induced TGF-β1 and TGF-β2 enhance airway epithelial repair via HB-EGF and TGF-α Biochem Biophys Res Commun 412 2011 109 114
46. A.D. Widgerow Cellular/extracellular matrix cross-talk in scar evolution and control Wound Repair Regen 19 2011 117 133
47. R.K. Coker, G.J. Laurent, P.K. Jeffery, R.M. du Bois, C.M. Black, and R.J. McAnulty Localisation of transforming growth factor β1 and β3 mRNA transcripts in normal and fibrotic human lung Thorax 56 2001 549 556
48. G. Murakozy, K.I. Gaede, G. Zissel, M. Schlaak, and J. Muller-Quernheim Analysis of gene polymorphisms in interleukin-10 and transforming growth factor-β 1 in sarcoidosis Sarcoidosis Vasc Diffuse Lung Dis 18 2001 165 169
49. A. Kruit, J.C. Grutters, and H.J. Ruven Transforming growth factor-β gene polymorphisms in sarcoidosis patients with and without fibrosis Chest 129 2006 1584 1591
50. T. Yoshida, A. Ohnuma, H. Horiuchi, and T. Harada Pulmonary fibrosis in response to environmental cues and molecular targets involved in its pathogenesis J Toxicol Pathol 24 2011 9 24
51. L. Farkas, D. Farkas, J. Gauldie, D. Warburton, W. Shi, and M. Kolb Transient overexpression of Gremlin results in epithelial activation and reversible fibrosis in rat lungs Am J Respir Cell Mol Biol 44 2011 870 878
52. M. Myllarniemi, P. Lindholm, and M.J. Ryynanen Gremlin-mediated decrease in bone morphogenetic protein signaling promotes pulmonary fibrosis Am J Respir Crit Care Med 177 2008 321 329
53. M. Heron, C.H. van Moorsel, and J.C. Grutters Genetic variation in GREM1 is a risk factor for fibrosis in pulmonary sarcoidosis Tissue Antigens 77 2011 112 117
54. T.A. Wynn Fibrotic disease and the T(H)1/T(H)2 paradigm Nat Rev Immunol 4 2004 583 594
55. V. Barbarin, Z. Xing, M. Delos, D. Lison, and F. Huaux Pulmonary overexpression of IL-10 augments lung fibrosis and Th2 responses induced by silica particles Am J Physiol Lung Cell Mol Physiol 288 2005 L841 L848
56. T.A. Wynn Fibrotic disease and the T(H)1/T(H)2 paradigm Nat Rev Immunol 4 2004 583 594
57. F.Q. Wen, T. Kohyama, and X. Liu Interleukin-4- and interleukin-13- enhanced transforming growth factor-β2 production in cultured human bronchial epithelial cells is attenuated by interferon-γ Am J Respir Cell Mol Biol 26 2002 484 490
58. M. Gharaee-Kermani, E.M. Denholm, and S.H. Phan Costimulation of fibroblast collagen and transforming growth factor β1 gene expression by monocyte chemoattractant protein-1 via specific receptors J Biol Chem 271 1996 17779 17784
59. S.W. Park, M.H. Ahn, and H.K. Jang Interleukin-13 and its receptors in idiopathic interstitial pneumonia: clinical implications for lung function J Korean Med Sci 24 2009 614 620
60. C.E. Rose Jr., S.S. Sung, and S.M. Fu Significant involvement of CCL2 (MCP-1) in inflammatory disorders of the lung Microcirculation 10 2003 273 278
61. S.L. Kunkel, S.W. Chensue, N. Lukacs, and C. Hogaboam Cytokine phenotypes serve as a paradigms for experimental immune-mediated lung diseases and remodeling Am J Respir Cell Mol Biol 29 2003 S63 S66
62. T.T. MacDonald Decoy receptor springs to life and eases fibrosis Nat Med 12 2006 13 14
63. M. Kaviratne, M. Hesse, and M. Leusink IL-13 activates a mechanism of tissue fibrosis that is completely TGF-β independent J Immunol 173 2004 4020 4029
64. H.P. Hauber, D. Gholami, A. Meyer, and A. Pforte Increased interleukin-13 expression in patients with sarcoidosis Thorax 58 2003 519 524
65. V. Palchevskiy, N. Hashemi, and S.S. Weigt Immune response CC chemokines CCL2 and CCL5 are associated with pulmonary sarcoidosis Fibrogenesis Tissue Repair 4 2011 10
66. X. Liu, A.M. Das, and J. Seideman The CC chemokine ligand 2 (CCL2) mediates fibroblast survival through IL-6 Am J Respir Cell Mol Biol 37 2007 121 128
67. H.Y. Reynolds Lung inflammation and fibrosis: an alveolar macrophage-centered perspective from the 1970s to 1980s Am J Respir Crit Care Med 171 2005 98 102
68. A. Prasse, D.V. Pechkovsky, and G.B. Toews A vicious circle of alveolar macrophages and fibroblasts perpetuates pulmonary fibrosis via CCL18 Am J Respir Crit Care Med 173 2006 781 792
69. D.V. Pechkovsky, A. Prasse, and F. Kollert Alternatively activated alveolar macrophages in pulmonary fibrosis-mediator production and intracellular signal transduction Clin Immunol 137 2010 89 101
70. G. Liu, H. Ma, and L. Qiu Phenotypic and functional switch of macrophages induced by regulatory CD4+CD25+ T cells in mice Immunol Cell Biol 89 2011 130 142
71. I.G. Luzina, N. Tsymbalyuk, and J. Choi CCL18-stimulated upregulation of collagen production in lung fibroblasts requires Sp1 signaling and basal Smad3 activity J Cell Physiol 206 2006 221 228
72. D.M. Mosser The many faces of macrophage activation J Leukoc Biol 73 2003 209 212
73. M.J. Miller, and M.B. Grisham Nitric oxide as a mediator of inflammation?-You had better believe it Mediators Inflamm 4 1995 387 396
74. F.O. Martinez, L. Helming, and S. Gordon Alternative activation of macrophages: an immunologic functional perspective Annu Rev Immunol 27 2009 451 483
75. R.C. Benson, K.A. Hardy, and C.R. Morris Arginase and arginine dysregulation in asthma J Allergy (Cairo) 2011 2011 736319
76. M. Munder, K. Eichmann, and M. Modolell Alternative metabolic states in murine macrophages reflected by the nitric oxide synthase/arginase balance: competitive regulation by CD4+ T cells correlates with Th1/Th2 phenotype J Immunol 160 1998 5347 5354
77. F. Porcheray, S. Viaud, and A.C. Rimaniol Macrophage activation switching: an asset for the resolution of inflammation Clin Exp Immunol 142 2005 481 489
78. R.D. Stout, and J. Suttles Functional plasticity of macrophages: reversible adaptation to changing microenvironments J Leukoc Biol 76 2004 509 513
79. S. Prokop, F.L. Heppner, H.H. Goebel, and W. Stenzel M2 polarized macrophages and giant cells contribute to myofibrosis in neuromuscular sarcoidosis Am J Pathol 178 2011 1279 1286
80. M. Wiken, F. Idali, M.A. Al Hayja, J. Grunewald, A. Eklund, and J. Wahlstrom No evidence of altered alveolar macrophage polarization, but reduced expression of TLR2, in bronchoalveolar lavage cells in sarcoidosis Respir Res 11 2010 121
81. L.L. Koth, O.D. Solberg, J.C. Peng, N.R. Bhakta, C.P. Nguyen, and P.G. Woodruff Sarcoidosis blood transcriptome reflects lung inflammation and overlaps with tuberculosis Am J Respir Crit Care Med 184 2011 1153 1163
82. B.A. Rybicki, M.J. Maliarik, M. Major, J. Popovich Jr., and M.C. Iannuzzi Epidemiology, demographics, and genetics of sarcoidosis Semin Respir Infect 13 1998 166 173
83. American Thoracic Society Idiopathic pulmonary fibrosis: diagnosis and treatment. International consensus statement. American Thoracic Society (ATS), and the European Respiratory Society (ERS) Am J Respir Crit Care Med 161 2000 646 664
84. B.A. Rybicki, M. Major, J. Popovich Jr., M.J. Maliarik, and M.C. Iannuzzi Racial differences in sarcoidosis incidence: a 5-year study in a health maintenance organization Am J Epidemiol 145 1997 234 241
85. M. Selman, T.E. King, and A. Pardo Idiopathic pulmonary fibrosis: prevailing and evolving hypotheses about its pathogenesis and implications for therapy Ann Intern Med 134 2001 136 151
86. T.A. Wynn Integrating mechanisms of pulmonary fibrosis J Exp Med 208 2011 1339 1350
87. B.D. Bringardner, C.P. Baran, T.D. Eubank, and C.B. Marsh The role of inflammation in the pathogenesis of idiopathic pulmonary fibrosis Antioxid Redox Signal 10 2008 287 301
88. J.C. Bonner, A.B. Rice, and J.L. Ingram Susceptibility of cyclooxygenase-2-deficient mice to pulmonary fibrogenesis Am J Pathol 161 2002 459 470
89. J. Wilborn, L.J. Crofford, M.D. Burdick, S.L. Kunkel, R.M. Strieter, and M. Peters-Golden Cultured lung fibroblasts isolated from patients with idiopathic pulmonary fibrosis have a diminished capacity to synthesize prostaglandin E2 and to express cyclooxygenase-2 J Clin Invest 95 1995 1861 1868
90. P.D. Bozyk, and B.B. Moore Prostaglandin E2 and the pathogenesis of pulmonary fibrosis Am J Respir Cell Mol Biol 45 2011 445 452
91. Z. Borok, A. Gillissen, and R. Buhl Augmentation of functional prostaglandin E levels on the respiratory epithelial surface by aerosol administration of prostaglandin E Am Rev Respir Dis 144 1991 1080 1084
92. M.R. Hill, A. Papafili, and H. Booth Functional prostaglandin- endoperoxide synthase 2 polymorphism predicts poor outcome in sarcoidosis Am J Respir Crit Care Med 174 2006 915 922
93. I. Kotsianidis, E. Nakou, and I. Bouchliou Global impairment of CD4+CD25+FOXP3+ regulatory T cells in idiopathic pulmonary fibrosis Am J Respir Crit Care Med 179 2009 1121 1130